Ribosomal Protein S12 P4: Potential Drug Target and Biomarker

Target Name: RPS12P4

NCBI ID: G391370

RPS12P4

Other Name(s): ribosomal protein S12 pseudogene 4 | Ribosomal protein S12 pseudogene 4 | RPS12_1_210

Ribosomal Protein S12 P4: Potential Drug Target and Biomarker

Ribosomal protein S12 pseudogene 4 (RPS12P4) is a protein that is expressed in most eukaryotic cells. It is a key component of the ribosome, which is the protein machine that synthesizes proteins in the cell. RPS12P4 plays a critical role in the proper functioning of the ribosome, and it is often used as a drug target or biomarker in scientific research.

RPS12P4 is a 21-kDa protein that is composed of 156 amino acid residues. It is located on the 5S rRNA molecule, which is the largest class of RNA in the cell. The 5S rRNA molecule is responsible for synthesizing the amino acids that make up the ribosome, and RPS12P4 is a key component of this process.

One of the unique features of RPS12P4 is its ability to interact with small molecules, such as drugs. This interaction allows RPS12P4 to serve as a drug target, or biomarker, in scientific research. Many drugs work by binding to specific proteins, and RPS12P4 is a good example of such a protein.

RPS12P4 is often used as a drug target because of its involvement in the ribosome. Drugs that work by modifying the ribosome can potentially interfere with the production of proteins, which can have a variety of effects on the cell. For example, some drugs are used to treat cancer by inhibiting the production of proteins that are involved in cell growth and division. By targeting RPS12P4, these drugs can effectively inhibit the production of these proteins and potentially slow down or even stop the growth of cancer cells.

In addition to its potential as a drug target, RPS12P4 is also widely used as a biomarker in scientific research. Ribosomal proteins are often used as biomarkers because they are highly stable and can be used to detect changes in the cell over time. For example, RPS12P4 can be used to detect changes in the amount of protein synthesized by the cell over time, which can be an indicator of disease.

Another potential use of RPS12P4 as a biomarker is its ability to be modified by small molecules. This modification can be used to tag RPS12P4 with a fluorescent or radioactive label, which can be used to visualize the protein in the cell. This is a useful technique for studying the localization and stability of RPS12P4 in the cell.

In conclusion, RPS12P4 is a protein that is expressed in most eukaryotic cells and plays a critical role in the functioning of the ribosome. Its ability to interact with small molecules makes it a potential drug target, and its use as a biomarker has been widely recognized in scientific research. Further studies are needed to fully understand the role of RPS12P4 in the cell and its potential as a drug or biomarker.

Protein Name: Ribosomal Protein S12 Pseudogene 4

The "RPS12P4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPS12P4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets